JP7334114B2 - drug action device - Google Patents

Description

The present invention relates to, for example, a drug acting device for acting a drug.

Conventionally, for example, as a drug action device for acting two different drugs, there is known one in which a first drug and a second drug are placed adjacent to each other and housed in a container (Patent Document 1).

JP-A-8-24322

Drugs work better when they have more surface area exposed to air. However, when two types of drugs are placed adjacent to each other in contact with each other as in Patent Document 1 described above, the function of each drug is reduced by the amount of the contact surface, and the function that can be originally exhibited is reduced. .

SUMMARY OF THE INVENTION It is an object of the present invention to provide a drug acting device capable of separating two different storage locations for drugs and allowing the drugs to function effectively. .

One aspect of the drug action device of the present invention includes a first holding member that holds a first drug in an annular shape , and a second holding member that holds a second drug so as to be arranged inside the first drug. , a first position with the second drug disposed inside the first drug , and a second position with the second drug axially displaced from the first position and withdrawn from the first drug; and support means that relatively movably supported the first holding member and the second holding member therebetween.

ADVANTAGE OF THE INVENTION According to one aspect of the present invention, it is possible to provide a drug action device in which two different drug storage locations can be separated and the drug can be effectively functioned.

FIG. 1 is an external perspective view showing the drug acting device according to the first embodiment. FIG. 2 is a cross-sectional view of the drug action device of FIG. 1 cut along line F2-F2. FIG. 3 is a cross-sectional view showing a state where the cover body of the drug action device of FIG. 2 is closed. FIG. 4 is an external perspective view showing a drug acting device according to a second embodiment. FIG. 5 is an external perspective view showing a drug acting device according to a third embodiment. FIG. 6 is an external perspective view showing a drug acting device according to a fourth embodiment.

BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, embodiments of the present invention will be described with reference to the drawings.
(First embodiment)
As shown in FIG. 1, the drug action device 10 of the first embodiment includes a container body 1 (first holding member) containing a first drug Y1 and a lid body 2 holding a second drug Y2. (Second holding member). The lid 2 has an open position (second position) shown in FIGS. 1 and 2 in which the opening 1a of the container body 1 is opened, and a closed position (first position) shown in FIG. 3 in which the opening 1a is closed. , and is movably attached to the container body 1 between. In this embodiment, as an example, the first drug Y1 contained in the container body 1 is a deodorant, and the second drug Y2 held by the lid 2 is an aromatic. The first drug Y1 and the second drug Y2 are formed in a solid or gel form.

The container body 1 is made of polypropylene (PP) resin, for example. The lid 2 is made of polyethylene (PE) resin, for example. The materials of the container body 1 and the lid 2 are not limited to those mentioned above. ) resin, synthetic resin such as polyvinyl chloride (PVC) resin, or glass or metal other than synthetic resin.

The deodorants housed in the container body 1 are, for example, plant extract deodorants such as eucalyptus oil and green tea polyphenol, ionic compound deodorants such as sodium bicarbonate and citric acid, and mineral deodorants such as silica gel and zeolite. and microporous deodorants such as coconut shell activated carbon, and these deodorants are gelled or kneaded into synthetic resin to form a solid. The fragrant held by the lid 2 is, for example, a natural fragrance or a synthetic fragrance that is gelled or kneaded into a synthetic resin to be solid.

In the present embodiment, the deodorant is contained in the container body 1 and the lid 2 holds the aromatic. Odorants may be retained. Also, both the first and second agents Y1 and Y2 can be deodorants or fragrances. In addition to deodorants and fragrances, various chemicals such as disinfectants, antibacterial agents, preservatives, and antioxidants can be used or mixed.

The container body 1 has a substantially cylindrical peripheral wall 1b and a substantially circular bottom wall 1c that closes one axial end (lower end in the drawing) of the peripheral wall 1b. The shape of the container body 1 is not limited to a cylindrical shape as in the present embodiment, and may be any shape. A substantially cylindrical partition wall 3 having a diameter smaller than that of the peripheral wall 1b protrudes integrally from the inner surface of the bottom wall 1c. The partition wall 3 is arranged coaxially with the peripheral wall 1b inside the peripheral wall 1b. The axial height of the partition wall 3 is substantially the same as the axial height of the peripheral wall 1b. The first drug Y1 is accommodated and arranged in an annular accommodation space 4 between the inner surface of the peripheral wall 1b and the outer surface of the partition wall 3. As shown in FIG. The upper surface of the first drug Y1 is located slightly lower than the upper end 1d of the peripheral wall 1b of the container body 1 and slightly lower than the upper end 3a of the partition wall 3 .

As shown in FIGS. 2 and 3 , the container body 1 has a substantially cylindrical slide sleeve 5 with a smaller diameter than the partition wall 3 inside the partition wall 3 at a position radially spaced from the partition wall 3 . The slide sleeve 5 is arranged coaxially with the partition wall 3 and coaxially with the peripheral wall 1b. One end (lower end in the drawing) of the slide sleeve 5 is integrated with the bottom wall 1c. A through-hole 1e continuous with the inner surface of the slide sleeve 5 is provided in the center of the bottom wall 1c. The height of the slide sleeve 5 is also the same as the height of the peripheral wall 1b and the partition wall 3. Near the other end (upper end in the figure) of the slide sleeve 5, an annular engaging stepped portion 5a protrudes. The engagement step portion 5 a is provided on the inner surface side of the slide sleeve 5 . A substantially cylindrical movement space 6 is provided between the outer surface of the slide sleeve 5 and the inner surface of the partition wall 3 .

The lid body 2 integrally has a substantially circular top wall 2a that closes the opening 1a of the container body 1 and a substantially cylindrical peripheral wall 2b. A knob 2c protrudes from the outer surface of the top wall 2a. The diameters of the top wall 2a and the peripheral wall 2b are slightly larger than the diameter of the bottom wall 1c of the container body 1 and are large enough to cover the opening 1a. For this reason, when the lid 2 is placed in the closed position shown in FIG. lower surface in the drawing) contacts the upper end 1 d of the peripheral wall 1 b of the container body 1 . At this time, the upper end 3a of the partition wall 3 of the container body 1 is also brought into contact with the inner surface of the top wall 2a of the lid 2. As shown in FIG.

The lid body 2 integrally has a substantially annular projection 11 having a diameter smaller than that of the peripheral wall 2b on the inner surface of the top wall 2a. The inner diameter of the protrusion 11 is slightly larger than the outer diameter of the partition wall 3 of the container body 1 . The protrusion 11 receives the upper end 3a of the partition wall 3 inside thereof when the lid body 2 is placed in the closed position to close the opening 1a of the container body 1 (FIG. 3). As described above, the annular projection 11 for receiving the upper end 3a of the partition wall 3 of the container body 1 is provided on the inner surface of the top wall 2a of the lid 2, so that the lid 2 can be closed in the closed position shown in FIG. , the storage space 4 for storing the first medicine Y1 and the movement space 6 inside thereof can be reliably partitioned. That is, the partition wall 3 and the protrusion 11 partition the first drug Y1 and the second drug Y2 in a non-contact state when the lid 2 is placed at the closed position.

The lid 2 has a substantially cylindrical retaining sleeve 12 with a smaller diameter than the projection 11 and arranged coaxially with the projection 11 at a position spaced radially inward of the projection 11 . The holding sleeve 12 protrudes in a direction substantially orthogonal to the top wall 2a. One end (upper end in the figure) of the holding sleeve 12 in the axial direction is integrated with the inner surface of the top wall 2 a of the lid 2 . The protrusion height of the holding sleeve 12 is set to be substantially the same as the height of the partition wall 3 of the container body 1 and the slide sleeve 5 .

The outer peripheral surface 12a of the holding sleeve 12 holds the second drug Y2. That is, the second drug Y2 is provided in a cylindrical shape along the outer peripheral surface 12a of the holding sleeve 12. As shown in FIG. The second medicine Y2 is provided over substantially the entire length of the holding sleeve 12 . The holding sleeve 12 and the second drug Y2 are arranged in the movement space 6 between the partition wall 3 of the container body 1 and the slide sleeve 5 with the lid 2 arranged in the closed position. The holding sleeve 12 and the second drug Y2 are movable within the movement space 6 according to the opening/closing operation of the lid 2. As shown in FIG. In other words, the thickness of the second drug Y2 is the same as that of the holding sleeve 12 and the second drug Y2 in the moving space 6 with a slight gap between the outer peripheral surface of the second drug Y2 and the inner surface of the partition wall 3. is set to a thickness that allows movement.

The lid body 2 has a substantially cylindrical slide shaft 13 smaller in diameter than the holding sleeve 12 inside the holding sleeve 12 . The slide shaft 13 is arranged coaxially with the retaining sleeve 12 . One end (upper end in the drawing) of the slide shaft 13 is integrated with the inner surface of the ceiling wall 2a of the lid 2 . The slide shaft 13 extends vertically from the inner surface of the top wall 2a. The slide shaft 13 is slightly shorter than the slide sleeve 5 of the container body 1 . The slide shaft 13 has an outer diameter slightly smaller than the inner diameter of the slide sleeve 5 . A substantially cylindrical gap 14 is provided between the outer peripheral surface of the slide shaft 13 and the inner peripheral surface of the holding sleeve 12 .

An engagement claw 13a is provided at the other end (lower end in the figure) of the slide shaft 13 . The engaging claw 13 a is provided on the outer surface of the slide shaft 13 . The other end of the slide shaft 13 is divided into a plurality of parts in the circumferential direction, and the engaging claw 13a is also divided into a plurality of parts along the circumferential direction. The slide sleeve 5 of the container body 1, the holding sleeve 12 of the lid 2, and the slide shaft 13 of the lid 2 function as support means for supporting the container body 1 and the lid 2 so as to be relatively axially movable. .

When assembling the drug action device 10 having the structure described above, the slide shaft 13 of the lid body 2 is inserted into the slide sleeve 5 from the upper end side of the slide sleeve 5 of the container body 1 in the drawing. At this time, the slide sleeve 5 of the container body 1 is inserted into the gap 14 between the slide shaft 13 of the lid 2 and the holding sleeve 12 .

When the slide shaft 13 of the lid body 2 is inserted into the slide sleeve 5 of the container body 1, the other end of the slide shaft 13 is elastically deformed so as to curve inward, and the engaging claw 13a engages the engaging step portion of the slide sleeve 5. Overcome 5a. When the slide shaft 13 is further moved within the slide sleeve 5 , the engaging claw 13 a of the slide shaft 13 , which has moved slightly inward due to elastic deformation, returns to its original position, and the engaging claw 13 a engages the slide sleeve 5 . It engages with the stepped portion 5a. In this state (state shown in FIG. 2), it is possible to prevent the slide shaft 13 from coming off the slide sleeve 5 .

Actions and effects of the drug action device 10 described above will be described below.
The drug action device 10 is shipped with the lid 2 in the closed position shown in FIG. In this state, the first drug Y1 and the second drug Y2 are not exposed to the outside air. At the time of use, the user pulls up the lid body 2 from the container body 1 by holding the knob 2c, and draws out the second drug Y2 from the movement space 6 of the container body 1. - 特許庁This state is shown in FIGS. This operation opens the opening 1a of the container body 1 and exposes the surface 7 (first surface) of the first drug Y1 to the atmosphere. Also, at this time, the surface 8 (second surface) of the second chemical Y2 is exposed to the atmosphere. That is, by moving the lid 2 away from the container body 1, the surfaces 7 and 8 of the first and second drugs Y1 and Y2 can be exposed to the atmosphere at the same time.

Therefore, according to the present embodiment, the first drug Y1 can be effectively functioned, and the second drug Y2 can be effectively operated by simply opening the lid 2 at the start of use of the drug action device 10. can function. In this embodiment, since the deodorant is stored in the container main body 1, the deodorizing effect can be exhibited by opening the lid 2. FIG. Further, in the present embodiment, since the lid 2 holds the aromatic substance, volatilization of the aromatic component can be started by opening the lid 2 .

Further, according to this embodiment, by adjusting the degree of opening of the lid 2, the degree of functioning of the first and second drugs Y1 and Y2 can be adjusted. For example, by opening the lid body 2 wide (FIG. 2), a large amount of air can be circulated along the surface 7 of the first drug Y1 accommodated in the container body 1, thereby maximizing the deodorizing effect. be able to. On the other hand, by slightly opening the lid 2, the amount of air contacting the surface 7 of the first medicine Y1 can be reduced, and the deodorizing effect can be set to be exhibited for a long time.

Further, for example, by opening the lid 2 wide (FIG. 2), the second drug Y2 held on the side of the lid 2 can be pulled out from the moving space 6 of the container body 1, thereby releasing the second drug Y2. The surface area of the surface 8 exposed to the atmosphere can be increased, and the volatilization amount of the aromatic component can be maximized. On the other hand, by slightly opening the lid 2, the amount of the second chemical Y2 withdrawn can be reduced, the surface area of the surface 8 of the second chemical Y2 exposed to the air can be reduced, and the aromatic component volatilizes. You can also reduce the amount to make the fragrance milder.

As described above, according to the present embodiment, by relatively moving the container main body 1 holding the first drug Y1 and the lid 2 holding the second drug Y2, the first drug Y1 is removed from the atmosphere. , and the surface area of the second drug Y2 exposed to the air can be increased. Therefore, according to this embodiment, both the first drug Y1 and the second drug Y2 can effectively function at the same time.

In this embodiment, the container body 1 is provided with the partition wall 3 to prevent the first drug Y1 and the second drug Y2 from directly facing (or contacting), but the partition wall 3 is not necessarily required. , the first drug Y1 is formed of a solid or gel material that can maintain its shape at room temperature, and a hole through which the second drug Y2 can be inserted is provided in the center of the first drug Y1. You may make it insert and arrange|position the 2nd chemical|medical agent Y2 to a hole in a non-contact state. In this case, by opening the lid 2, the surface of the second drug Y2 is exposed, and at the same time, the inner surface (first surface) of the hole of the first drug Y1 is also exposed to the air, so that the first drug is exposed to the air. Y1 can act more effectively.

(Second embodiment)
As shown in FIG. 4, a drug action device 20 according to the second embodiment has a structure in which a container body 21 and a lid body 22 are connected by a hinge mechanism (support means) (not shown). Also in this embodiment, the shape of the container main body 21 and the shape of the lid body 22 can be arbitrarily changed. Here, constituent elements that function in the same manner as in the above-described first embodiment are denoted by the same reference numerals, and detailed description thereof will be omitted.

A substantially oval opening 23 is provided on the upper surface side of the container body 21 in the drawing. The lid 22 is rotatable by a hinge mechanism between the illustrated open position (second position) and the unillustrated closed position (first position) that closes the opening 23 of the container body 21 . ing. The lid body 22 is formed in a substantially oval plate shape.

The internal space of the container body 21 is partitioned into three regions by two partition walls 24a and 24b that are spaced parallel to each other. A first drug Y1 is accommodated and arranged in two regions outside the two partition walls 24a and 24b. The two regions may contain the same type of first drug Y1 or may contain different types of first drug Y1. The surface 7 (first surface) of the first drug Y1 is provided at a position slightly lower than the upper end of the container body 21 .

The inner surface 22a of the lid 22 is provided with the second medicine Y2. The second drug Y2 has a semicylindrical shape obtained by dividing a cylinder into two in the radial direction, and protrudes from the inner surface 22a of the lid body 22 . On the other hand, in the area between the two partition walls 24a and 24b of the container body 21, a curved bottom wall 25 having a shape substantially matching the surface shape of the second drug Y2 is provided. Since the surface of the second drug Y is curved in the direction of rotation, the second drug Y can be prevented from interfering with other members when the lid body 22 is opened and closed. Instead of providing the bottom wall 25, another drug Y3 having an upper surface having the same shape as the shape of the bottom wall 25 may be accommodated and arranged in this area.

When the opening 23 of the container body 21 is closed with the lid 22, the second drug Y2 is inserted into the central region of the container body 21 in a nested manner. In this state, the curved outer surface 26 of the second drug Y2 faces the bottom wall 25 of the container body 21. As shown in FIG. Therefore, when the lid 22 is closed, the first medicine Y1 accommodated and arranged in the container body 21 is hardly exposed to the outside air, and the surface of the second medicine Y2 held by the lid 22 is exposed to the outside air. nor exposed.

From this state, when the lid 22 is rotated to the illustrated state and opened, the opening 23 of the container body 21 is opened, and the surface 7 of the first medicine Y1 is exposed to the outside air. A surface (second surface) including the outer surface 26 of the provided second chemical Y2 is also exposed to the outside air. Therefore, in this embodiment as well, the action of opening the lid 22 allows the first drug Y1 to function effectively, and the second drug Y2 to function effectively.

When another drug Y3 (not shown) is accommodated and arranged without providing the bottom wall 25 in the central region of the container body 21, opening the lid 22 allows the other drug Y3 to be curved on the upper surface (first surface) can be exposed to the atmosphere, allowing the drug Y3 to function effectively. Although the first to third chemicals Y1, Y2, and Y3 are not described as specific substances in this embodiment, the first to third chemicals Y1, Y2, and Y3 are deodorants and fragrances. Any drug can be used in combination arbitrarily.

(Third embodiment)
As shown in FIG. 5, a drug acting device 30 according to the third embodiment includes a first holding member 31 holding a first drug Y1 and a second holding member 32 holding a second drug Y2. It has a structure that is rotatably connected via a hinge mechanism 33 (supporting means). The first holding member 31 has a housing portion 31a capable of housing the second holding member 32 therein. The first holding member 31 may be formed by molding the first drug Y1 into a solid or gel form, and the second holding member 32 is also formed by molding the second drug Y2 into a solid or gel form. may be

From the state (first position) in which the second holding member 32 is accommodated in the accommodation portion 31a of the first holding member 31, the second holding member 32 is rotated to the illustrated state and opened (second position). position) and the inner surface 34 (first surface) of the housing portion 31a of the first holding member 31 are exposed to the outside air, and the surface 35 of the second holding member 32 facing the inner surface of the housing portion 31a. (second surface) is exposed.

Therefore, in the present embodiment as well, the operation of rotating the second holding member 32 to the illustrated position enables the first drug Y1 to function effectively and the second drug Y2 to effectively operate. can function. Further, by enabling the angle of the hinge mechanism 33 to be adjusted, the effect can be exhibited step by step.

(Fourth embodiment)
As shown in FIG. 6, a drug action device 40 according to the fourth embodiment includes a first holding member 41 holding a first drug Y1 and a second holding member 42 holding a second drug Y2. It has a structure slidably connected via a slide mechanism 43 (support means). The slide mechanism 43 includes, for example, a slide rail 43a provided on the inner surface of the housing portion 41a of the first holding member 41 and a slide groove 43b provided on the surface of the second holding member 42. As shown in FIG.

The first holding member 41 has a housing portion 41a (supporting means) capable of housing the second holding member 42 therein. The first holding member 41 may be formed by molding the first drug Y1 into a solid or gel form, and the second holding member 42 is also formed by molding the second drug Y2 into a solid or gel form. may be

When the second holding member 42 is pulled out to the illustrated state (second position) from the state (first position) in which the second holding member 42 is housed in the housing portion 41a of the first holding member 41, , the inner surface 44 (first surface) of the housing portion 41a of the first holding member 41 is exposed to the outside air, and the surface 45 (second surface) of the second holding member 42 opposed to the inner surface of the housing portion 41a. ) is exposed.

Therefore, in this embodiment as well, the operation of pulling out the second holding member 42 to the illustrated position enables the first drug Y1 to function effectively and the second drug Y2 to function effectively. be able to. Further, by making it possible to adjust the relative position of the second holding member 42 with respect to the first holding member 41 by the slide mechanism 43, the effect can be adjusted.

The present invention has been described above based on several embodiments, but the present invention is not limited to the above-described embodiments, and various modifications and applications are possible within the scope of the present invention. is of course.
The invention described in the scope of claims at the time of filing of the present application will be additionally described below.
[1]
a first holding member holding a first drug;
a second holding member holding a second drug;
The first drug covers the first surface facing the second drug and/or the second holding member with the second drug and/or the second holding member, and the second drug is covered with the second drug and/or the second holding member. a first position where a drug covers a second surface facing the first drug and/or the first holding member with the first drug and/or the first holding member; The first holding member and the second holding member are placed relative to each other between a second position where the first surface of the drug is released and the second surface of the second drug is released. a support means supported to be movably supported;
A drug action device comprising:
[2]
The first holding member partitions the first drug and the second drug in a non-contact state with the first holding member and the second holding member arranged at the first position. having a partition wall that
The drug action device of [1].
[3]
The first drug and the second drug are formed in a solid or gel form,
The drug action device of [1] or [2].
[4]
the first agent is a deodorant,
wherein the second agent is a fragrance;
The drug action device of [3].
[5]
a first holding member holding a first drug;
holding a second drug, provided movably relative to the first holding member, and moving relative to the first holding member to release the first drug into the atmosphere; a second holding member that increases the contact surface area and the air contact surface area of the second agent, compared to before movement;
A drug action device comprising:
[6]
The first holding member has a partition partitioning the first drug and the second drug in a non-contact state before the movement,
The drug action device of [5].
[7]
The first drug and the second drug are formed in a solid or gel form,
The drug action device of [5] or [6].
[8]
the first agent is a deodorant,
wherein the second agent is a fragrance;
8. The drug effect device of claim 7.

DESCRIPTION OF SYMBOLS 1... Container main body 2... Lid body 3... Partition wall 4... Storage space 5... Slide sleeve 6... Moving space 7, 8... Surface 10, 20, 30, 40... Drug action device, 12... Holding Sleeve 13 Slide shaft 14 Gap Y1 First medicine Y2 Second medicine.

Claims (4)

a first holding member holding the first drug in an annular shape ;
a second holding member holding the second drug so as to be arranged inside the first drug ;
a first position in which the second drug is disposed inside the first drug ; and a second position in which the second drug is axially displaced from the first position and withdrawn from the first drug. a support means for supporting the first holding member and the second holding member so as to be relatively movable between a position of
A drug action device comprising: The first holding member partitions the first drug and the second drug in a non-contact state with the first holding member and the second holding member arranged at the first position. having a partition wall that
2. The drug action device of claim 1. The first drug and the second drug are formed in a solid or gel form,
3. A drug action device according to claim 1 or claim 2. the first agent is a deodorant,
wherein the second agent is a fragrance;
4. The drug action device of claim 3.